Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2007
12/26/2007CN101094659A Nanoparticle composition and methods for synthesis thereof
12/26/2007CN101092414A Preparation and application of a category of 6 ¿C aryl ¿C 3 ¿C cycroamido methyl pyrone derviation
12/26/2007CN101092409A C-aryl glucoside sglt2 inhibitors and method
12/26/2007CN101092405A Derivative of new benzothiadiazines, preparation method and usage
12/26/2007CN101092397A Structure modified compound of sinomenine, and prepartion method
12/26/2007CN101091795A Prevention and treatment of synucleinopathic disease
12/26/2007CN101091791A Injection of brain peptide, and preparation method
12/26/2007CN101091790A Oral taking brain peptide, and preparation method
12/26/2007CN101091788A Oral liquid for stopping drug addiction
12/26/2007CN101091783A Preparation of Chinese traditional medicine for treating HIV infection, AIDS, tumours etc. multiple difficult diseases
12/26/2007CN101091782A Pearl pill, and preparation method
12/26/2007CN101091776A Recovering pellet for dispelling epilepsy
12/26/2007CN101091763A Method for controlling quality of tonic tablet for essence and blood
12/26/2007CN101091715A Composition of medication for treating cardiovascular diseases and cerebrovascular diseases
12/26/2007CN101091713A Tripterine capsule in use for preventing and treating disease of nerve damage, preparation method and usage
12/26/2007CN101091709A Combination of vitamin C and vitamin B6 in use for dispelling the effects of alcohol
12/26/2007CN101091706A Excitant of dopamine transport protein and usage
12/26/2007CN101091700A Composition of slow (controled) releasing preparation of Quetiadine Hemifumarate, and application
12/26/2007CN101091697A Aerosol of brain peptide and preparation method
12/26/2007CN100357293C Diazinopyrimidines
12/26/2007CN100357281C Bicyclic compounds, process for their preparation and pharmaceutical composition containing them
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/26/2007CN100357274C Diaryl-enynes
12/26/2007CN100357270C D-proline derivative
12/26/2007CN100357008C Apparatus and method for manufacturing tabasheer
12/26/2007CN100356982C Adeno-associated virus vector preparation and medicinal composition containing it and its use
12/26/2007CN100356951C Medicine for strengtherning brain and tranquilizing mind
12/26/2007CN100356940C Method for preparing piper laetispicum extract, extract and its use
12/26/2007CN100356923C Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
12/26/2007CN100356911C Compressed-shaping formulation for hypnosis
12/26/2007CN100356907C Controlled release dosage forms using acrylic polymer, and process for making
12/25/2007US7312360 Substituted hydroxyethylamines
12/25/2007US7312344 Dimeric isoflavones
12/25/2007US7312342 Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof
12/25/2007US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically
12/25/2007US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders
12/25/2007US7312321 Antibody to human enzymes of the metalloprotease family
12/25/2007US7312304 Somatostatin agonists
12/25/2007US7312246 Inhibiting interaction of alpha-helical protein with another protein or binding site; inhibiting cellular invasion of HIV
12/25/2007US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/25/2007US7312230 Carboxylic acid derivatives as IP antagonists
12/25/2007US7312227 Autoimmune diseases; Alzheimer's disease; Parkinson's disease; bone disorders; liver disorders; rheumatic disease; amythrophiic lateral sclerosis
12/25/2007US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
12/25/2007US7312188 Alzheimer's disease; for promoting secretion of amyloid precursor protein-alpha (sAPP)
12/25/2007US7311932 sports drinks containing micronutrients, proteins and viable lactobacillus having positive effect on human intestinal mucous membranes
12/25/2007US7311905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
12/21/2007WO2007146225A2 Heterocyclic aspartyl protease inhibitors
12/21/2007WO2007146202A2 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
12/21/2007WO2007146178A1 A method of reducing amyloid-beta peptide levels using a bisdioxopiperazine
12/21/2007WO2007146122A2 Tetrahydropyrido[3,4-d]pyrimidines and related analogues
12/21/2007WO2007146116A2 Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
12/21/2007WO2007146088A1 Salicyl alcohol creatine phosphate prodrugs, compositions and uses thereof
12/21/2007WO2007146085A2 Creatine phosphate prodrugs, compositions and uses thereof
12/21/2007WO2007146073A2 Method for enhancing cognitive function
12/21/2007WO2007146066A2 Novel piperazines, pharmaceutical compositions and methods of use thereof
12/21/2007WO2007145889A1 Methods of treating spinal cord injury and minimizing scarring
12/21/2007WO2007145874A1 Anti-nicotine treatment comprising use of three anticholinergic agents
12/21/2007WO2007145589A1 Peptides that are capable of binding to amyloid-beta peptide.
12/21/2007WO2007145571A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007WO2007145570A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007WO2007145569A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007WO2007145568A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue
12/21/2007WO2007145208A1 Peptide derivative
12/21/2007WO2007144979A1 Peptide derivative
12/21/2007WO2007144676A2 Use of echinacea or preparations thereof in compositions for the treatment of anxiety
12/21/2007WO2007144628A1 Use of pharmaceutical compositions comprising cannabigerol for the treatment of depression
12/21/2007WO2007144422A2 Combination preparations comprising bifeprunox and l-dopa
12/21/2007WO2007144390A1 Use of a p38 kinase inhibitor for treating psychiatric disorders
12/21/2007WO2007144379A1 Bicyclic compounds useful as cathepsin s inbhibitors
12/21/2007WO2007144315A1 Use of 1,7-dimethylxanthine for the manufacture of a non-anxiogenic psychoanaleptic drug for the treatment of a neuropsychiatric disorder
12/21/2007WO2007144198A2 Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases
12/21/2007WO2007144196A2 Peptide compounds for treating refractory status epilepticus
12/21/2007WO2007144195A2 Pharmaceutical composition with synergistic anticonvulsant effect
12/21/2007WO2007144083A2 Ache-nmda combination wafer
12/21/2007WO2007144080A2 Combination antidepressants wafer
12/21/2007WO2007144006A1 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
12/21/2007WO2007144005A1 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
12/21/2007WO2007143930A1 Use of 20(s)-protopanoxadiol in manufacture of antidepressants
12/21/2007WO2007143851A1 Fermented plant extracts, methods of production and uses
12/21/2007WO2007122634A3 Pyrimidinediones as tyrosine kinase inhibitors
12/21/2007WO2007121721A3 Therapeutic target molecules for the development of novel medicaments for degenerative diseases
12/21/2007WO2007112014A3 New therapeutic combinations for the treatment of depression
12/21/2007WO2007111983A8 New therapeutic combinations for the treatment or prevention of psychotic disorders
12/21/2007WO2007106236A3 Pyrrolo-pyridine kinase modulators
12/21/2007WO2007063418A3 Substituted indole compounds having nos inhibitory activity
12/21/2007WO2007026224A3 5-ht1b antagonist composition for depression, anxiety and cognition
12/21/2007WO2007012761A8 Novel polysubstituted 1,1-pyridinyl aminocyclopropanamine derivatives, method for preparing same and pharmaceutical compositions containing same
12/21/2007WO2007006790A3 Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist
12/21/2007WO2007001225A8 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators.
12/21/2007WO2006103342A8 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/21/2007CA2784304A1 Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
12/21/2007CA2682755A1 Fermented plant extracts, methods of production and uses
12/21/2007CA2659512A1 Novel piperazines, pharmaceutical compositions and methods of use thereof
12/21/2007CA2657390A1 Use of a p38 kinase inhibitor for treating psychiatric disorders
12/21/2007CA2655243A1 Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
12/21/2007CA2655094A1 Use of pharmaceutical compositions comprising cannabigerol for the treatment of depression
12/21/2007CA2654891A1 Use of 1,7-dimethylxanthine for the manufacture of a non-anxiogenic psychoanaleptic drug for the treatment of a neuropsychiatric disorder
12/21/2007CA2654842A1 Thienopyrimidines useful as modulators of ion channels
1 ... 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 ... 1833